Education
About Us
Working with TipRanks
Follow Us
Biotage AB (SE:BIOT)
:BIOT
BIOT Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr81.60 - kr202.20
Previous CloseN/A
Volume45.29K
Average Volume (3M)578.78K
Market Cap
kr11.45B
Enterprise Valuekr12.02B
Total Cash (Recent Filing)kr420.00M
Total Debt (Recent Filing)kr238.00M
Price to Earnings (P/E)44.7
Beta0.92
Next Earnings
Jul 16, 2025EPS Estimate
0.7Last Dividend Ex-Date
Apr 25, 2025Dividend Yield11.13%
Share Statistics
EPS (TTM)3.20
Shares Outstanding80,049,270
10 Day Avg. Volume235,391
30 Day Avg. Volume578,777
Financial Highlights & Ratios
PEG Ratio1.56
Price to Book (P/B)7.48
Price to Sales (P/S)0.00
P/FCF Ratio45.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
kr143.02Price Target Upside0.02% Upside
Rating ConsensusHold
Number of Analyst Covering0
Biotage AB News
PremiumCompany Announcements
Biotage AB Increases Voting Rights Through Share Reclassification
PremiumCompany Announcements
Biotage AB Reports Q1 2025 Earnings Decline
PremiumCompany Announcements
Biotage AB Reports Strong 2024 Financial PerformanceOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.61%
Mutual Funds
― Other Institutional Investors
92.96% Public Companies and
Individual Investors
BIOT FAQ
What was Biotage AB’s price range in the past 12 months?
Biotage AB lowest stock price was kr81.60 and its highest was kr202.20 in the past 12 months.
What is Biotage AB’s market cap?
Biotage AB’s market cap is kr11.45B.
When is Biotage AB’s upcoming earnings report date?
Biotage AB’s upcoming earnings report date is Jul 16, 2025 which is in 17 days.
How were Biotage AB’s earnings last quarter?
Biotage AB released its earnings results on Apr 23, 2025. The company reported kr0.62 earnings per share for the quarter, beating the consensus estimate of kr0.22 by kr0.4.
Is Biotage AB overvalued?
According to Wall Street analysts Biotage AB’s price is currently Undervalued.
Does Biotage AB pay dividends?
Biotage AB pays a Annually dividend of kr15.923 which represents an annual dividend yield of 11.13%. See more information on Biotage AB dividends here
What is Biotage AB’s EPS estimate?
Biotage AB’s EPS estimate is 0.7.
How many shares outstanding does Biotage AB have?
Biotage AB has 80,049,270 shares outstanding.
What happened to Biotage AB’s price movement after its last earnings report?
Biotage AB reported an EPS of kr0.62 in its last earnings report, beating expectations of kr0.22. Following the earnings report the stock price went up 0.142%.
Which hedge fund is a major shareholder of Biotage AB?
Currently, no hedge funds are holding shares in SE:BIOT
Company Description
Biotage AB
Biotage AB is a global life sciences company headquartered in Sweden, specializing in solutions in organic and analytical chemistry. The company provides instruments, consumables, and services designed to enhance the efficiency and productivity of scientists working in fields such as drug discovery, analytical chemistry, and environmental testing. Biotage's core product offerings include chromatography systems, sample preparation solutions, and synthesis tools, catering to a diverse range of industries including pharmaceuticals, biotechnology, and academia.
BIOT Company Deck
BIOT Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and performance in the Astrea business and recurring revenues, yet faced challenges in meeting demand in the peptide segment and significant downturns in the China market and small molecules segment.Read More>Technical Analysis
AddLife AB
―
RaySearch Laboratories AB
―
BONESUPPORT HOLDING AB
―
Xvivo Perfusion AB
―